Search Results 1691-1700 of 17363 for magnesiummagnesium

1. Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation - Mayo Clinic

   Participation eligibility · eGFR < 30 mL/min/1.73 m2, serum creatinine > 2.5 mg/dL or requiring dialysis · Known permanent or current atrial fibrillation (history ...

2. Gemcitabine Hydrochloride in Treating Patients with Locally Advanced Pancreatic Cancer - Mayo Clinic

   Creatinine ≤ 1.5 mg/dL; Negative pregnancy test done ≤ 14 days prior to registration, for women of childbearing potential only; Provide informed written ...

3. Safety and Effectiveness of an Intracranial Aneurysm Embolization System for Treating Large or Giant Wide Neck Aneurysms - Mayo Clinic

   Subject has a serum creatinine level greater than 2.5mg/dL (within 7 days of procedure) which the investigator determines restricts the use of contrast agents ...

4. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   For HCC: Serum bilirubin >2.0 mg/dl (unless segmental infusion is planned47); For other primary or secondary liver neoplasis, bilirubin levels will be ...

5. Publications - Megan N. Wasson, D.O. - Mayo Clinic

   Delara R, Knuttinen MG, Wasson M. Vulvar Varicosities from May-Thurner Syndrome. J Minim Invasive Gynecol. 2020 May - Jun; 27 (4):798-799 Epub 2019 Aug 30

6. Immune Response to Antigens - Mayo Clinic

   NOTE: Inhaled steroids, low-dose corticosteroids (e.g. equivalent to or less than oral prednisone 10 mg daily), and steroid use for primary prevention of ...

7. A Study of the Use of the Hansen Medical System in Patients with Paroxysmal Atrial Fibrillation - Mayo Clinic

   Creatinine > 2.5 mg/dl (or > 221 µmol/L). Unstable angina. Myocardial infarction within the previous 60 days. Left ventricular ejection fraction less than ...

8. A Study to Evaluate the Safety, Tolerability, and Effectiveness of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis - Mayo Clinic

   Total bilirubin < 2 mg/dL, unless the individual is known to have Gilbert's syndrome or hemolytic anemia;; International normalized ratio (INR) ≤ 1.4 ...

9. Clinical Study Comparing PillCam ® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease - Mayo Clinic

   Low dose aspirin regimens (< 100 mg daily) are acceptable and not exclusionary. Subject suffers from any condition, such as swallowing problems, that ...

10. Study of Reslizumab in Patients With Uncontrolled Asthma and Elevated Blood Eosinophils - Mayo Clinic

    The primary objective of this study is to determine the effect of reslizumab (110 mg) administered subcutaneously every 4 weeks on clinical asthma ...